Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maria Grazia Vitale
Observed names:
M.G. Vitale,
Maria G Vitale,
Maria Grazia. Vitale,
Maria Vitale
Institution:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Observed institutions:
University of Udine,
University of Campania "Luigi Vanvitelli",
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale",
Azienda sanitaria universitaria Friuli Centrale
ORCID:
0000-0003-2331-5315
Observed ORCID:
0000-0003-2331-5315
OpenAlex ID:
A5007787317
Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice
2020
·
Alessio Cortellini
, Marco Tucci
, et al.
·
Journal for ImmunoTherapy of Cancer
·
293
PDF
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
2020
·
Francesco Perrone
, Maria Carmela Piccirillo
, et al.
·
Journal of Translational Medicine
·
149
PDF
BRAF Gene and Melanoma: Back to the Future
2021
·
Margaret Ottaviano
, Emilio Giunta
, et al.
·
International Journal of Molecular Sciences
·
130
PDF
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index
2020
·
Sebastiano Buti
, Melissa Bersanelli
, et al.
·
European Journal of Cancer
·
127
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial
2024
·
Paolo A. Ascierto
, Milena Casula
, et al.
·
Nature Communications
·
111
PDF
Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy
2020
·
Vincenzo Montesarchio
, Roberto Parrella
, et al.
·
Journal for ImmunoTherapy of Cancer
·
90
PDF
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer
2023
·
Alessio Cortellini
, Antonio D'Alessio
, et al.
·
Clinical Cancer Research
·
87
PDF
Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study
2022
·
F. Dimitriou
, K. Namikawa
, et al.
·
Annals of Oncology
·
75
PDF
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
2024
·
Brigida Anna Maiorano
, Massimo Di Maio
, et al.
·
JAMA Network Open
·
67
Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
2021
·
Aljosja Rogiers
, Ines Pires da Silva
, et al.
·
Journal for ImmunoTherapy of Cancer
·
64
PDF
Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study
2024
·
Mario Mandalà
, Paul Lorigan
, et al.
·
European Journal of Cancer
·
56
PDF
Anorectal and Genital Mucosal Melanoma: Diagnostic Challenges, Current Knowledge and Therapeutic Opportunities of Rare Melanomas
2022
·
Margaret Ottaviano
, Emilio Francesco Giunta
, et al.
·
Biomedicines
·
40
PDF
SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study
2021
·
Mario Mandala
, Paul Lorigan
, et al.
·
Journal for ImmunoTherapy of Cancer
·
37
PDF
The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases – A multicenter cohort study
2022
·
Carl-Jacob Holmberg
, Lars Ny
, et al.
·
European Journal of Cancer
·
33
PDF
Atezolizumab for the treatment of breast cancer
2018
·
Debora Basile
, Giacomo Pelizzari
, et al.
·
Expert Opinion on Biological Therapy
·
30
An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival
2020
·
Francesco Mannavola
, Mario Mandala
, et al.
·
Frontiers in Oncology
·
29
PDF
Immunotherapy in Metastatic Melanoma: A Novel Scenario of new Toxicities and their Management
2019
·
Ester Simeone
, Antonio M Grimaldi
, et al.
·
Melanoma Management
·
28
PDF
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab
2023
·
Domenico Mallardo
, Ester Simeone
, et al.
·
Journal of Translational Medicine
·
24
PDF
Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarization
2022
·
Domenico Mallardo
, Ester Simeone
, et al.
·
Journal of Translational Medicine
·
24
PDF
Melanoma immunotherapy: strategies to overcome pharmacological resistance
2020
·
Claudia Trojaniello
, Maria Grazia Vitale
, et al.
·
Expert Review of Anticancer Therapy
·
23
Advances in Melanoma and Skin Cancers
2025
·
Domenico Mallardo
, Debora Basile
, et al.
·
International Journal of Molecular Sciences
·
22
PDF
Immunotherapy for older patients with melanoma: From darkness to light?
2020
·
Donatella Iacono
, Maria Grazia Vitale
, et al.
·
Pigment Cell & Melanoma Research
·
22
PDF
Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis
2022
·
Domenico Mallardo
, Diana Giannarelli
, et al.
·
Journal for ImmunoTherapy of Cancer
·
21
PDF
The Use of Tocilizumab in Patients with COVID-19: A Systematic Review, Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Studies
2021
·
Alberto Enrico Maraolo
, Anna Crispo
, et al.
·
Journal of Clinical Medicine
·
21
PDF
Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis
2021
·
Maria Antonietta Isgrò
, Maria Grazia Vitale
, et al.
·
Journal of Translational Medicine
·
21
PDF
Show more works
View as search
Works count:
170
Citation count:
1,790
H-index:
22
I10-index:
31
Year
Topic
Type